
  
    
      
        Background_NNP
        High-resolution_NNP genetic_JJ maps_NNS are_VBP essential_JJ to_TO
        identifying_VBG and_CC characterizing_VBG the_DT gene_NN (_( s_VBZ )_) contributing_VBG to_TO
        diseases_NNS ,_, that_WDT is_VBZ ,_, they_PRP are_VBP essential_JJ for_IN making_VBG the_DT
        transition_NN from_IN positional_JJ cloning_VBG to_TO the_DT positional_JJ
        candidate_NN approach_NN ._. If_IN the_DT physical_JJ order_NN of_IN markers_NNS used_VBN
        for_IN linkage_NN analysis_NN is_VBZ incorrect_JJ ,_, the_DT position_NN of_IN the_DT
        putative_JJ locus_JJ may_MD at_IN best_JJS be_VB incorrect_JJ and_CC at_IN worst_JJS be_VB
        found_VBN not_RB to_TO exist_VB in_IN the_DT true_JJ interval_NN ._. We_PRP were_VBD hampered_VBN
        in_IN our_PRP$ efforts_NNS to_TO fine_VB map_NN the_DT gene_NN for_IN the_DT Blau_NNP syndrome_NN
        because_IN we_PRP were_VBD faced_VBN with_IN an_DT uncertain_JJ marker_NN order_NN in_IN
        maps_NNS that_WDT had_VBD many_JJ inconsistencies_NNS ._.
        The_DT Blau_NNP syndrome_NN (_( MIM_NNP 186580_CD )_) ,_, an_DT autosomal_NN dominant_JJ
        granulomatous_JJ disease_NN of_IN childhood_NN ,_, is_VBZ a_DT rare_JJ familial_NN
        granulomatous_JJ disease_NN [_NN 1_CD ]_NN ._. Affected_NNP individuals_NNS
        typically_RB display_NN one_CD or_CC more_JJR of_IN the_DT following_VBG
        granulomatous_JJ inflammations_NNS that_WDT have_VBP variable_JJ
        age-at-onset_JJ :_: acute_JJ anterior_NN uveitis_NNS ,_, arthritis_NN ,_, and_CC skin_NN
        rash_NN ._. The_DT phenotype_NN of_IN the_DT Blau_NNP syndrome_NN resembles_VBZ another_DT
        multisystem_NN granulomatous_JJ disorder_NN ,_, Crohn_NNP 's_POS disease_NN (_( MIM_NNP
        266600_CD )_) ,_, and_CC another_DT autoimmune_JJ disease_NN ,_, psoriasis_NNS (_( MIM_NNP
        177900_CD )_) ._. These_DT three_CD inflammatory_JJ diseases_NNS not_RB only_RB share_VB
        phenotypic_JJ features_NNS ,_, but_CC a_DT subset_NN of_IN putative_JJ risk_NN loci_NN
        mapped_VBN to_TO an_DT overlapping_VBG region_NN on_IN chromosome_NN 16_CD ._. Of_IN the_DT
        several_JJ putative_JJ susceptibility_NN loci_NN for_IN Crohn_NNP 's_POS disease_NN [_NN
        2_CD 3_CD 4_CD 5_CD 6_CD 7_CD ]_NN and_CC psoriasis_NNS [_NN 8_CD ]_NN ,_, the_DT Crohn_NNP 's_POS locus_JJ on_IN
        16_CD q_NN between_IN markers_NNS D_NNP 16_CD S_NNP 409_CD and_CC D_NNP 16_CD S_NNP 419_CD (_( 56_CD ._. 1_LS -_: 65_CD ._. 6_CD cM_NN from_IN
        p-terminus_JJ )_) [_NN 5_CD ]_NN and_CC the_DT psoriasis_NNS locus_JJ on_IN 16_CD q_NN near_IN
        D_NNP 16_CD S_NNP 3110_CD [_NN 8_CD ]_NN overlap_VB with_IN the_DT locus_JJ for_IN the_DT Blau_NNP
        syndrome_NN ._. Interestingly_RB ,_, another_DT autoimmune_JJ disease_NN
        ankylosing_VBG spondylitis_NNS (_( MIM_NNP 106300_CD )_) ,_, also_RB maps_NNS to_TO
        chromosome_NN 16_CD q_NN ,_, however_RB ,_, it_PRP appears_VBZ to_TO map_VB telomeric_JJ to_TO the_DT
        Blau_NNP syndrome_NN interval_NN [_NN 9_CD 10_CD ]_NN ._.
        While_IN our_PRP$ studies_NNS were_VBD in_IN progress_NN ,_, other_JJ groups_NNS
        detected_VBD mutations_NNS in_IN the_DT CARD_NNP 15_CD gene_NN for_IN a_DT subset_NN of_IN
        Crohn_NNP 's_POS disease_NN patients_NNS ,_, and_CC in_IN three_CD small_JJ Blau_NNP syndrome_NN
        families_NNS [_NN 11_CD 12_CD ]_NN ._. The_DT lack_NN of_IN accurate_JJ maps_NNS is_VBZ reflected_VBN
        in_IN the_DT position_NN assigned_VBN to_TO CARD_NNP 15_CD in_IN consecutive_JJ genome_NN
        builds_VBZ in_IN that_DT CARD_NNP 15_CD should_MD map_VB to_TO the_DT 16_CD q_NN 13_CD interval_NN for_IN
        Blau_NNP and_CC Crohn_NNP 's_POS ,_, yet_RB in_IN build_VB 27_CD it_PRP was_VBD mapped_VBN close_RB to_TO
        the_DT p-telomere_JJ of_IN chromosome_NN 16_CD ._. In_IN the_DT current_JJ build_VB ,_, 29_CD ,_,
        it_PRP is_VBZ located_VBN correctly_RB (_( see_VB additional_JJ data_NNS file_VBP 1_CD ,_,
        blau_NN __NN map_NN ._. pdf_NN )_) ._. Until_IN the_DT draft_NN human_JJ genome_NN is_VBZ truly_RB
        complete_JJ ,_, detailed_JJ regional_JJ physical_JJ maps_NNS will_MD be_VB
        indispensable_JJ for_IN genetic_JJ studies_NNS ._.
        Additional_JJ files_NNS 1_CD
        Physical_JJ map_NN of_IN the_DT Blau_NNP syndrome_NN interval_NN showing_VBG BAC_NNP
        clone_NN contigs_NNS and_CC markers_NNS ._. G_NNP 3_CD RH_NNP indicates_VBZ the_DT map_NN ,_,
        generated_VBN from_IN radiation_NN hybrid_JJ data_NNS ,_, which_WDT was_VBD used_VBN to_TO
        estimate_VB the_DT size_NN of_IN each_DT gap_NN in_IN the_DT BAC_NNP contigs_NNS ._. NCBI_NNP 25_CD
        is_VBZ the_DT map_NN based_VBN on_IN NCBI_NNP build_VB 25_CD ,_, the_DT map_NN from_IN the_DT NCBI_NNP
        that_WDT was_VBD current_JJ when_WRB the_DT BAC_NNP contig_NN was_VBD constructed_VBN and_CC is_VBZ
        shown_VBN at_IN the_DT top_NN ._. NCBI_NNP 29_CD is_VBZ the_DT current_JJ map_NN based_VBN on_IN NCBI_NNP
        build_VB 29_CD ._. Horizontal_NNP arrowheads_NNS with_IN "_'' Cen_NNP "_'' and_CC "_'' Tel_NNP "_''
        indicate_VBP the_DT orientation_NN of_IN the_DT centromere_NN and_CC q-telomere_JJ
        respectively_RB ._. Transcripts_NNP ,_, using_VBG HUGO_NNP (_( LocusLink_NNP )_) symbols_NNS
        of_IN named_VBN loci_NN are_VBP indicated_VBN below_IN the_DT scale_NN line_NN of_IN build_VB
        29_CD ._. Boxed_NNP symbols_NNS indicate_VBP that_IN the_DT genes_NNS were_VBD located_VBN on_IN
        clones_NNS in_IN this_DT study_NN ,_, either_CC to_TO locate_VB them_PRP or_CC to_TO verify_VB
        their_PRP$ location_NN ._. Horizontal_NNP lines_NNS above_IN transcript_NN symbols_NNS
        indicate_VBP approximate_JJ placement_NN ._. For_IN the_DT BAC_NNP contig_NN ,_,
        horizontal_NN lines_NNS are_VBP schematic_JJ representations_NNS of_IN BAC_NNP
        clones_NNS and_CC are_VBP not_RB to_TO scale_VB ;_: BACs_NNP are_VBP identified_VBN by_IN text_NN
        below_IN each_DT horizontal_NN line_NN ._. BAC_NNP clones_NNS are_VBP shown_VBN in_IN
        clusters_NNS according_VBG to_TO the_DT library_NN ,_, CITB_NNP or_CC RPC-_NNP 11_CD ,_, from_IN
        which_WDT they_PRP were_VBD isolated_VBN ._. Vertical_NNP bars_NNS indicate_VBP BAC_NNP clones_NNS
        that_WDT are_VBP positive_JJ for_IN the_DT corresponding_JJ markers_NNS indicated_VBD
        in_IN vertical_JJ text_NN above_IN the_DT BAC_NNP contigs_NNS ._. Two_CD genes_NNS ,_, matrix_NN
        metalloproteinase_NN 2_CD (_( MMP_NNP 2_LS )_) and_CC carboxylesterase_NN 1_CD (_( CES_NNP 1_LS )_)
        were_VBD mapped_VBN using_VBG markers_NNS developed_VBN here_RB and_CC are_VBP indicated_VBN
        as_IN boxed_JJ markers_NNS ._. Caspase_NNP recruitment_NN domain_NN family_NN member_NN
        15_CD (_( CARD_NNP 15_CD )_) was_VBD located_VBN to_TO 327_CD F_NN 22_CD using_VBG an_DT exon_NN 4_CD -_: specific_JJ
        PCR_NNP and_CC is_VBZ also_RB indicated_VBN as_IN a_DT boxed_JJ marker_NN ._. A_DT dotted_JJ line_NN
        box_NN around_IN clones_NNS indicates_VBZ the_DT specific_JJ clones_NNS that_WDT
        differed_VBD between_IN the_DT FPC_NNP contigs_NNS and_CC this_DT map_NN ._. Numbered_NNP
        vertical_JJ arrows_NNS on_IN the_DT bottom_NN indicate_VBP the_DT three_CD gaps_NNS in_IN
        the_DT BAC_NNP contig_NN ._.
        Click_NNP here_RB for_IN file_NN
        We_PRP have_VBP previously_RB reported_VBN that_IN the_DT Blau_NNP syndrome_NN
        susceptibility_NN region_NN resided_VBN between_IN D_NNP 16_CD S_NNP 298_CD and_CC D_NNP 16_CD S_NNP 408_CD [_NN
        13_CD ]_NN ._. Here_RB we_PRP generated_VBD a_DT high-resolution_JJ map_NN extending_VBG
        from_IN D_NNP 16_CD S_NNP 3080_CD ,_, near_IN D_NNP 16_CD S_NNP 409_CD ,_, to_TO D_NNP 16_CD S_NNP 408_CD and_CC placed_VBN four_CD
        plausible_JJ candidate_NN genes_NNS (_( CES_NNP 1_CD ,_, MMP_NNP 2_CD ,_, MMP_NNP 15_CD and_CC SCYA_NNP 17_CD )_) in_IN
        the_DT map_NN ._. We_PRP also_RB excluded_VBD the_DT four_CD candidate_NN genes_NNS as_IN the_DT
        genes_NNS harbouring_VBG mutations_NNS causing_VBG the_DT Blau_NNP syndrome_NN ._.
      
      
        Results_NNS
        
          High-resolution_NNP RH_NNP map_NN
          To_TO generate_VB a_DT framework_NN order_NN of_IN markers_NNS ,_, we_PRP used_VBD
          three_CD RH_NNP panels_NNS (_( Table_NNP 1_LS )_) and_CC the_DT RHMAP_NNP program_NN package_NN ._.
          We_PRP typed_VBN the_DT GeneBridge_NNP 4_CD panel_NN for_IN 54_CD markers_NNS to_TO verify_VB
          that_IN they_PRP occurred_VBD near_IN ,_, or_CC in_IN ,_, the_DT interval_NN between_IN
          D_NNP 16_CD S_NNP 409_CD and_CC D_NNP 16_CD S_NNP 408_CD ._. The_DT G_NNP 3_CD panel_NN was_VBD typed_VBN for_IN a_DT total_NN
          of_IN 77_CD markers_NNS and_CC the_DT TNG_NNP panel_NN for_IN 83_CD markers_NNS ._. The_DT
          markers_NNS were_VBD clustered_VBN into_IN linkage_NN groups_NNS by_IN two-point_JJ
          analyses_NNS using_VBG RH_NNP 2_CD PT_NNP and_CC a_DT criterion_NN of_IN a_DT lod_NN score_NN
          greater_JJR than_IN or_CC equal_JJ to_TO 4_CD ._. Multipoint_NNP analyses_NNS were_VBD
          performed_VBN on_IN linkage_NN groups_NNS as_RB well_RB as_IN sparse_NN linkage_NN
          groups_NNS together_RB with_IN markers_NNS from_IN other_JJ linkage_NN groups_NNS ._.
          Several_JJ multipoint_NN maximum_NN likelihood_NN framework_NN maps_NNS were_VBD
          constructed_VBN using_VBG the_DT RHMAXLIK_NNP program_NN of_IN the_DT RHMAP_NNP
          package_NN and_CC equal_JJ retention_NN probabilities_NNS and_CC the_DT branch_NN
          ordering_VBG scheme_NN options_NNS ,_, which_WDT gives_VBZ the_DT highest_JJS
          probability_NN of_IN finding_VBG the_DT correct_JJ order_NN [_NN 14_CD ]_NN ._. The_DT G_NNP 3_CD
          RH_NNP map_NN (_( see_VB additional_JJ data_NNS file_VBP 1_CD ,_, blau_NN __NN map_NN ._. pdf_NN )_)
          provided_VBD an_DT order_NN for_IN the_DT construction_NN of_IN the_DT BAC_NNP
          contigs_NNS ._. Although_IN the_DT TNG_NNP panel_NN generated_VBD a_DT useful_JJ map_NN ,_,
          there_EX were_VBD unresolved_JJ regions_NNS where_WRB it_PRP appeared_VBD that_IN the_DT
          panel_NN did_VBD not_RB provide_VB sufficient_JJ data_NNS to_TO differentiate_VB
          between_IN alternative_JJ marker_NN orders_NNS ._. We_PRP merged_VBD the_DT G_NNP 3_CD and_CC
          TNG_NNP data_NNS by_IN establishing_VBG a_DT G_NNP 3_CD framework_NN map_NN that_WDT fixed_VBD
          the_DT order_NN of_IN a_DT subset_NN of_IN markers_NNS ._. Clusters_NNP of_IN close_JJ
          markers_NNS containing_VBG at_IN least_JJS two_CD G_NNP 3_CD mapped_VBN markers_NNS were_VBD
          then_RB mapped_VBN relative_JJ to_TO one-another_JJ using_VBG the_DT TNG_NNP data_NN ._.
          By_IN integrating_VBG the_DT G_NNP 3_CD and_CC the_DT TNG_NNP maps_NNS ,_, an_DT overall_JJ
          contiguous_JJ RH_NNP map_NN of_IN the_DT region_NN between_IN the_DT markers_NNS
          D_NNP 16_CD S_NNP 411_CD and_CC D_NNP 16_CD S_NNP 415_CD was_VBD constructed_VBN in_IN which_WDT the_DT marker_NN
          order_NN of_IN most_JJS loci_NN could_MD be_VB determined_VBN with_IN a_DT likelihood_NN
          ratio_NN of_IN greater_JJR than_IN 300_CD :_: 1_CD over_IN the_DT next_JJ most_RBS likely_JJ
          order_NN (_( data_NNS not_RB shown_VBN )_) ._.
        
        
          BAC_NNP contig_NN construction_NN
          We_PRP carefully_RB selected_VBD STSs_NNP from_IN within_IN or_CC around_IN the_DT
          Blau_NNP candidate_NN interval_NN to_TO screen_VB two_CD BAC_NNP libraries_NNS ._. More_JJR
          than_IN 130_CD STSs_NNP were_VBD chosen_VBN from_IN those_DT in_IN known_VBN genes_NNS ,_,
          ESTs_NNP ,_, polymorphic_JJ microsatellite_NN markers_NNS ,_, random_JJ genomic_JJ
          sequences_NNS ,_, and_CC BAC_NNP end_NN sequences_NNS present_JJ in_IN databases_NNS ._.
          Construction_NNP of_IN a_DT BAC_NNP clone_NN contig_NN was_VBD initiated_VBN by_IN
          screening_VBG the_DT CITB_NNP library_NN with_IN all_PDT the_DT STS_NNP markers_NNS ._. The_DT
          clone_NN contigs_NNS were_VBD constructed_VBN based_VBN on_IN the_DT common_JJ BACs_NNP
          identified_VBN by_IN two_CD or_CC more_JJR markers_NNS ,_, using_VBG the_DT RH_NNP map_NN
          described_VBD above_IN and_CC the_DT existing_VBG framework_NN map_NN resources_NNS
          as_IN reference_NN for_IN ordering_VBG ._.
          We_PRP initially_RB identified_VBD 377_CD unique_JJ CITB_NNP clones_NNS with_IN
          one_CD or_CC more_JJR STS_NNP hits_NNS from_IN which_WDT a_DT subset_NN of_IN 41_CD clones_NNS
          that_WDT contained_VBD at_IN least_JJS two_CD markers_NNS was_VBD used_VBN to_TO construct_VB
          17_CD contig_NN clusters_NNS (_( see_VB additional_JJ data_NNS file_VBP 1_CD ,_,
          blau_NN __NN map_NN ._. pdf_NN )_) ._. These_DT 41_CD non-redundant_JJ CITB_NNP clones_NNS in_IN the_DT
          contigs_NNS covered_VBD less_JJR than_IN 50_CD %_NN of_IN the_DT broad_JJ Blau_NNP syndrome_NN
          interval_NN ._. The_DT remaining_VBG 336_CD CITB_NNP clones_NNS were_VBD redundant_JJ in_IN
          that_IN they_PRP either_DT were_VBD identified_VBN by_IN a_DT single_JJ marker_NN or_CC
          were_VBD identified_VBN by_IN the_DT same_JJ markers_NNS as_IN the_DT 41_CD
          non-redundant_JJ clones_NNS ._. Gaps_NNP in_IN the_DT contigs_NNS were_VBD closed_VBN by_IN
          a_DT combination_NN of_IN DNA_NNP sequence_NN alignments_NNS of_IN BESs_NNP with_IN
          HTGS_NNP data_NNS ,_, clone_NN walking_VBG using_VBG RNA_NNP probes_NNS from_IN end_NN clones_NNS
          to_TO hybridize_NN to_TO the_DT RPCI-_NNP 11_CD gridded_JJ filters_NNS ,_, and_CC
          verification_NN of_IN clone_NN positions_NNS by_IN PCR_NNP for_IN STSs_NNP ._. From_IN the_DT
          BAC_NNP contigs_NNS ,_, eight_CD clones_NNS from_IN both_DT ends_NNS of_IN the_DT contig_NN
          clusters_NNS were_VBD selected_VBN for_IN sequencing_VBG using_VBG T_NN 7_CD and_CC SP_NNP 6_CD
          primers_NNS ._. Sequence_NNP alignments_NNS with_IN these_DT 16_CD end_NN sequences_NNS
          revealed_VBD that_IN two_CD sequences_NNS ,_, CITB_NNP __NN 361_CD N_NNP 2_CD -_: T_NN 7_CD and_CC
          CITB_NNP __NN 520_CD M_NNP 7_CD -_: SP_NNP 6_CD ,_, identified_VBD one_CD common_JJ clone_NN from_IN the_DT
          online_NN HTGS_NNP ,_, which_WDT was_VBD RPCI-_NNP 11_CD __NN 147_CD B_NNP 17_CD (_( Figure_NN 1_LS )_) ._.
          BES_NNP alignment_NN was_VBD a_DT very_RB feasible_JJ and_CC practical_JJ
          technique_NN for_IN filling_VBG in_IN the_DT gaps_NNS with_IN the_DT availability_NN
          of_IN an_DT ever-increasing_JJ number_NN of_IN BAC_NNP clone_NN sequences_NNS in_IN
          online_NN databases_NNS ._. Using_VBG this_DT approach_NN ,_, one_CD gap_NN between_IN
          marker_NN D_NNP 16_CD S_NNP 2986_CD and_CC Cda_NNP 11_CD d_SYM 08_CD was_VBD closed_VBN ._. STS_NNP marker_NN
          D_NNP 16_CD S_NNP 2986_CD was_VBD initially_RB used_VBN to_TO search_VB the_DT HTGS_NNP data_NN and_CC
          one_CD clone_NN RPCI-_NNP 11_CD __NN 357_CD N_NNP 13_CD was_VBD retrieved_VBN with_IN 100_CD %_NN
          identity_NN ._. BES_NNP from_IN clone_NN 357_CD N_NNP 13_CD was_VBD then_RB used_VBN to_TO repeat_VB
          the_DT alignment_NN searches_NNS and_CC identified_VBD another_DT clone_NN
          RPCI-_NNP 11_CD __NN 488_CD J_NNP 11_CD ,_, which_WDT overlapped_JJ STS_NNP markers_NNS Cda_NNP 11_CD d_SYM 08_CD and_CC
          WI-_NNP 16741_CD ._.
          Two_CD rounds_NNS of_IN clone_NN walking_VBG were_VBD carried_VBN out_IN in_IN order_NN
          to_TO either_CC close_VB the_DT gaps_NNS or_CC verify_VB the_DT order_NN of_IN the_DT clone_NN
          contigs_NNS ._. All_DT the_DT plasmid_NN DNAs_NNP from_IN these_DT clones_NNS were_VBD
          isolated_VBN and_CC completely_RB digested_VBN by_IN 
          Hind_NNP III_NNP into_IN linear_JJ fragments_NNS for_IN
          run-off_JJ transcription_NN ._. Since_IN RNA_NNP probes_NNS were_VBD directly_RB
          transcribed_JJ from_IN human_JJ genomic_JJ sequence_NN ,_, it_PRP was_VBD necessary_JJ
          to_TO test_VB the_DT probes_NNS for_IN repetitive_JJ sequences_NNS ._. The_DT presence_NN
          of_IN repetitive_JJ sequences_NNS can_MD hinder_VB the_DT specific_JJ
          identification_NN of_IN BAC_NNP clones_NNS from_IN the_DT library_NN filters_NNS ._. Of_IN
          44_CD probes_NNS tested_VBN ,_, three_CD probes_NNS produced_VBD multiple_JJ bands_NNS
          with_IN the_DT genomic_JJ DNA_NNP indicating_VBG that_IN they_PRP contained_VBD
          repetitive_JJ sequences_NNS ,_, and_CC were_VBD ,_, therefore_RB ,_, excluded_VBN from_IN
          further_JJ analyses_NNS ._. We_PRP identified_VBD more_JJR than_IN 400_CD clones_NNS from_IN
          the_DT RPCI-_NNP 11_CD library_NN of_IN which_WDT 83_CD were_VBD incorporated_VBN (_( see_VB
          additional_JJ data_NNS file_VBP 1_CD ,_, blau_NN __NN map_NN ._. pdf_NN )_) ._. After_IN one_CD round_NN of_IN
          clone_NN walking_NN ,_, the_DT physical_JJ map_NN covered_VBN more_JJR than_IN 80_CD %_NN of_IN
          the_DT broad_JJ Blau_NNP syndrome_NN interval_NN ._. A_DT second_JJ round_NN
          increased_VBD coverage_NN to_TO greater_JJR than_IN 90_CD %_NN ._. Three_CD unresolved_JJ
          gaps_NNS remain_VBP in_IN the_DT physical_JJ map_NN (_( see_VB additional_JJ data_NNS file_VBP
          1_CD ,_, blau_NN __NN map_NN ._. pdf_NN )_) ._.
        
        
          Comparison_NNP of_IN BAC_NNP contig_NN to_TO other_JJ maps_NNS
          We_PRP compared_VBD our_PRP$ map_NN to_TO the_DT current_NN ,_, July_NNP 1_CD ,_, 2002_CD ,_,
          contigs_NNS generated_VBN by_IN fingerprinting_VBG and_CC available_JJ from_IN
          the_DT FPC_NNP database_NN at_IN Washington_NNP University_NNP Genome_NNP
          Sequencing_NNP Center_NNP ._. The_DT FPC_NNP database_NN has_VBZ few_JJ clones_NNS from_IN
          the_DT CITB_NNP library_NN and_CC none_NN that_WDT corresponded_VBD to_TO the_DT clones_NNS
          on_IN our_PRP$ map_NN (_( see_VB additional_JJ data_NNS file_VBP 1_CD ,_,
          blau_NN __NN map_NN ._. pdf_NN )_) ._.
          Of_IN 83_CD RPCI-_NNP 11_CD clones_NNS in_IN our_PRP$ contigs_NNS ,_, 63_CD were_VBD present_JJ
          in_IN the_DT FPC_NNP database_NN ;_: 1_CD was_VBD not_RB placed_VBN on_IN a_DT contig_NN ,_, 6_CD were_VBD
          placed_VBN on_IN contigs_NNS of_IN different_JJ chromosomes_NNS ,_, and_CC 56_CD in_IN
          three_CD chromosome_NN 16_CD contigs_NNS ,_, ctg_NN 16020_CD ,_, ctg_NN 16021_CD and_CC
          ctg_NN 16024_CD ._. The_DT gap_NN between_IN ctg_NN 16020_CD and_CC ctg_NN 16021_CD
          corresponds_NNS to_TO gap_NN 1_CD (_( see_VB additional_JJ data_NNS file_VBP 1_CD ,_,
          blau_NN __NN map_NN ._. pdf_NN )_) ._. FPC_NNP contig_NN ctg_NN 16020_CD is_VBZ oriented_VBN q-telomere_JJ
          to_TO centromere_NN ,_, i_NNP ._. e_SYM ._. reversed_VBD with_IN respect_NN to_TO our_PRP$ map_NN ._. One_CD
          clone_NN ,_, 420_CD D_NNP 3_CD was_VBD placed_VBN in_IN ctg_NN 16020_CD ,_, however_RB ,_, our_PRP$ data_NNS
          suggest_VBP it_PRP should_MD be_VB in_IN ctg_NN 16020_CD close_RB to_TO 122_CD K_NNP 22_CD and_CC
          444_CD I_PRP 18_CD ._. Our_PRP$ data_NNS also_RB reversed_VBD the_DT order_NN of_IN clones_NNS
          380_CD E_NNP 14_CD ,_, 210_CD K_NNP 18_CD and_CC 535_CD L_NNP 14_CD in_IN ctg_NN 16020_CD ._. Aside_RB from_IN one_CD
          minor_JJ difference_NN with_IN respect_NN to_TO clone_NN 444_CD I_PRP 18_CD that_IN our_PRP$
          data_NNS place_VBP slightly_RB closer_JJR to_TO the_DT q_NN telomere_NN ,_, the_DT
          remaining_VBG 37_CD clones_NNS of_IN contig_NN ctg_NN 16021_CD that_WDT were_VBD common_JJ
          to_TO both_DT maps_NNS agreed_VBD very_RB well_RB ._. There_EX was_VBD a_DT single_JJ clone_NN
          in_IN ctg_NN 16024_CD ,_, 463_CD J_NNP 22_CD that_IN our_PRP$ data_NNS place_VBP in_IN ctg_NN 16021_CD ,_, near_IN
          228_CD I_PRP 15_CD ._. Interestingly_RB ,_, one_CD of_IN the_DT clones_NNS ,_, 327_CD F_NN 22_CD ,_, that_WDT
          was_VBD placed_VBN on_IN a_DT contig_NN from_IN a_DT different_JJ chromosome_NN was_VBD
          the_DT clone_NN that_WDT contains_VBZ all_DT or_CC part_NN of_IN CARD_NNP 15_CD ._.
          The_DT NCBI_NNP build_VB current_JJ at_IN the_DT time_NN our_PRP$ map_NN was_VBD being_VBG
          finalized_VBN was_VBD build_VBN 25_CD (_( see_VB additional_JJ data_NNS file_VBP 1_CD ,_,
          blau_NN __NN map_NN ._. pdf_NN )_) ._. There_EX were_VBD a_DT large_JJ number_NN of_IN discrepancies_NNS
          between_IN our_PRP$ map_NN and_CC the_DT build_VB 25_CD map_NN ._. The_DT gene_NN
          subsequently_RB characterized_VBD as_IN having_VBG mutations_NNS in_IN Blau_NNP
          syndrome_NN families_NNS was_VBD not_RB in_IN the_DT interval_NN ._. The_DT
          discrepancies_NNS largely_RB remained_VBD until_IN builds_VBZ 28_CD and_CC 29_CD ._.
          Build_NNP 29_CD ,_, the_DT current_JJ build_VB ,_, of_IN NCBI_NNP agrees_VBZ very_RB well_RB
          with_IN our_PRP$ map_NN (_( see_VB additional_JJ data_NNS file_VBP 1_CD ,_,
          blau_NN __NN map_NN ._. pdf_NN )_) ._.
        
        
          Candidate_NNP genes_NNS
          Four_CD genes_NNS ,_, CES_NNP 1_CD ,_, MMP_NNP 2_CD ,_, MMP_NNP 15_CD and_CC SCYA_NNP 17_CD ,_, with_IN
          relevant_JJ biochemical_JJ functions_NNS based_VBN on_IN the_DT literature_NN
          and_CC with_IN map_NN locations_NNS in_IN the_DT broad_JJ Blau_NNP susceptibility_NN
          region_NN as_IN defined_VBN by_IN our_PRP$ initial_JJ DNA_NNP linkage_NN study_NN for_IN
          the_DT Blau_NNP syndrome_NN [_NN 13_CD ]_NN ,_, were_VBD considered_VBN as_IN candidates_NNS ._.
          CES_NNP 1_CD is_VBZ expressed_VBN in_IN mature_VBP monocytes_NNS and_CC macrophages_NNS ,_,
          and_CC is_VBZ involved_VBN in_IN the_DT degradation_NN of_IN xenobiotics_NNS [_NN 15_CD ]_NN
          ._. MMP_NNP 2_CD or_CC MMP_NNP 15_CD ,_, or_CC both_DT ,_, are_VBP connective_JJ tissue_NN degrading_JJ
          enzymes_NNS [_NN 16_CD ]_NN ._. A_DT hypothetical_JJ role_NN for_IN MMP_NNP 2_CD and_CC MMP_NNP 15_CD
          in_IN the_DT Blau_NNP syndrome_NN is_VBZ that_DT aberrant_NN expression_NN of_IN MMP_NNP 2_CD
          and_CC MMP_NNP 15_CD could_MD inappropriately_RB degrade_NN connective_JJ
          tissue_NN ,_, which_WDT ,_, in_IN turn_NN ,_, could_MD release_NN stored_VBD cytokines_NNS
          and_CC inflammatory_JJ mediators_NNS ,_, such_JJ as_IN tumor_NN necrosis_NNS factor_NN
          α_NN and_CC interleukins_NNS and_CC potentially_RB expose_VB neo-epitopes_JJ ._.
          SCYA_NNP 17_CD is_VBZ a_DT member_NN of_IN the_DT CC_NNP group_NN of_IN chemokines_NNS that_WDT is_VBZ
          involved_VBN in_IN immunoregulatory_NN and_CC inflammatory_JJ processes_VBZ [_NN
          17_CD 18_CD 19_CD ]_NN ._. It_PRP is_VBZ a_DT chemoattractant_NN for_IN T_NN lymphocytes_NNS
          and_CC is_VBZ expressed_VBN constitutively_RB in_IN thymus_JJ and_CC transiently_RB
          in_IN stimulated_VBN peripheral_JJ blood_NN monocytes_NNS [_NN 20_CD ]_NN ._.
          Interestingly_RB ,_, high_JJ levels_NNS of_IN expression_NN of_IN SCYA_NNP 17_CD were_VBD
          observed_VBN in_IN lipopolysaccharide-stimulated_JJ human_JJ monocytes_NNS
          [_NN 21_CD ]_NN ._. Sekiya_NNP et_CC al_NN ._. [_NN 22_CD ]_NN showed_VBD that_IN SCYA_NNP 17_CD
          potentially_RB played_VBD a_DT role_NN via_IN a_DT paracrine_NN mechanism_NN in_IN
          the_DT development_NN of_IN allergic_JJ respiratory_JJ diseases_NNS ._. Thus_RB ,_,
          inappropriate_JJ topical_JJ expression_NN of_IN SCYA_NNP 17_CD could_MD induce_VB a_DT
          localized_JJ immune_JJ or_CC auto-immune_JJ response_NN ._.
          A_DT total_NN of_IN 13_CD sequence_NN variants_NNS were_VBD identified_VBN in_IN the_DT
          promoter_NN region_NN of_IN the_DT CES_NNP 1_CD gene_NN (_( Table_NNP 2_LS )_) by_IN sequencing_VBG
          33_CD members_NNS from_IN the_DT Blau_NNP families_NNS ._. Seven_CD thirteen-marker_JJ
          haplotypes_NNS could_MD be_VB assigned_VBN unambiguously_RB (_( Table_NNP 3_LS )_)
          using_VBG extended_VBN pedigree_NN structures_NNS (_( data_NNS not_RB shown_VBN )_) ,_,
          however_RB ,_, none_NN of_IN them_PRP was_VBD associated_VBN with_IN the_DT Blau_NNP
          syndrome_NN phenotype_NN ._. The_DT CES_NNP 1_CD gene_NN was_VBD ,_, therefore_RB ,_,
          excluded_VBN as_IN a_DT candidate_NN for_IN the_DT Blau_NNP syndrome_NN ._.
          RH_NNP mapping_NN of_IN CES_NNP 1_CD and_CC MMP_NNP 2_CD placed_VBN them_PRP close_VBP ,_, and_CC
          centromeric_JJ ,_, to_TO D_NNP 16_CD S_NNP 408_CD (_( see_VB additional_JJ data_NNS file_VBP 1_CD ,_,
          blau_NN __NN map_NN ._. pdf_NN )_) ,_, whereas_IN MMP_NNP 15_CD and_CC SCYA_NNP 17_CD mapped_VBN telomeric_JJ
          to_TO D_NNP 16_CD S_NNP 408_CD ._. The_DT MMP_NNP 15_CD locus_JJ was_VBD placed_VBN between_IN D_NNP 16_CD S_NNP 408_CD
          and_CC D_NNP 16_CD S_NNP 494_CD using_VBG the_DT GeneBridge_NNP 4_CD RH_NNP panel_NN ._. CES_NNP 1_CD and_CC
          MMP_NNP 2_CD were_VBD mapped_VBN to_TO clones_NNS in_IN the_DT BAC_NNP contigs_NNS (_( see_VB
          additional_JJ data_NNS file_VBP 1_CD ,_, blau_NN __NN map_NN ._. pdf_NN )_) ,_, whereas_IN SCYA_NNP 17_CD and_CC
          the_DT markers_NNS Cda_NNP 1_CD jb_NN 12_CD and_CC R_NN 55777_CD were_VBD mapped_VBN to_TO the_DT BAC_NNP
          clones_NNS ,_, CITB_NNP __NN 387_CD I_PRP 12_CD ,_, CITB_NNP __NN 437_CD K_NNP 19_CD and_CC CITB_NNP __NN 229_CD H_NNP 3_CD ,_, which_WDT
          map_VBP 1_CD ._. 1_CD Mbp_NNP telomeric_JJ to_TO D_NNP 16_CD S_NNP 408_CD according_VBG to_TO the_DT NCBI_NNP
          human_JJ genomic_JJ data_NNS (_( data_NNS not_RB shown_VBN )_) ._. Our_PRP$ own_JJ RH_NNP distance_NN
          estimates_NNS also_RB place_VBP these_DT markers_NNS more_JJR than_IN 1_CD Mbp_NNP
          telomeric_JJ to_TO D_NNP 16_CD S_NNP 408_CD ._. In_IN our_PRP$ G_NNP 3_CD RH_NNP map_NN CES_NNP 1_CD was_VBD located_VBN
          outside_IN a_DT subsequently_RB refined_VBN Blau_NNP syndrome_NN interval_NN
          that_WDT excluded_VBD several_JJ cM_NN centromeric_JJ to_TO D_NNP 16_CD S_NNP 408_CD ,_, thus_RB
          confirming_VBG the_DT lack_NN of_IN association_NN between_IN CES_NNP 1_CD
          haplotypes_NNS and_CC the_DT disease_NN phenotype_NN ._.
          Mutations_NNP were_VBD characterized_VBN in_IN the_DT gene_NN CARD_NNP 15_CD for_IN a_DT
          few_JJ small_JJ families_NNS with_IN the_DT Blau_NNP syndrome_NN [_NN 11_CD 12_CD ]_NN ._. We_PRP
          have_VBP characterized_VBN additional_JJ mutations_NNS in_IN Blau_NNP syndrome_NN
          families_NNS ,_, however_RB ,_, only_RB five_CD of_IN ten_CD families_NNS had_VBD
          mutations_NNS in_IN the_DT exons_NNS and_CC flanking_VBG sequences_NNS (_( X_NNP ._. Wang_NNP ,_,
          H_NNP ._. Kuivaniemi_NNP ,_, G_NNP ._. Bonavita_NNP ,_, L_NNP ._. Mutkus_NNP ,_, U_NNP ._. Mau_NNP ,_, E_NNP ._. Blau_NNP ,_,
          N_NNP ._. Inohara_NNP ,_, G_NNP ._. Nunez_NNP ,_, G_NNP ._. Tromp_NNP and_CC C_NNP ._. J_NNP ._. Williams_NNP ;_: in_IN
          press_NN )_) ._. The_DT gene_NN was_VBD located_VBN in_IN the_DT approximate_JJ interval_NN
          both_DT cytologically_RB and_CC on_IN the_DT Santa_NNP Cruz_NNP map_NN
          http_NN :_: /_NN /_NN genome_NN ._. ucsc_NN ._. edu_NN /_NN cgi-bin_JJ /_NN hgGateway_NN ?_. db_NN =_SYM hg_NN 10_CD ,_, but_CC was_VBD
          located_VBN on_IN chromosome_NN 16_CD p_NN on_IN the_DT NCBI_NNP map_NN (_( builds_VBZ 25_CD to_TO
          28_CD )_) ._. We_PRP verified_VBN the_DT location_NN of_IN CARD_NNP 15_CD on_IN our_PRP$ map_NN by_IN
          amplifying_VBG a_DT 444_CD bp_NN fragment_NN of_IN exon_NN 4_CD from_IN clone_NN 327_CD F_NN 22_CD
          in_IN our_PRP$ map_NN (_( see_VB additional_JJ data_NNS file_VBP 1_CD ,_,
          blau_NN __NN map_NN ._. pdf_NN )_) ._.
        
      
      
        Discussion_NNP
        Correct_NNP marker_NN order_NN and_CC intermarker_NN distance_NN are_VBP
        essential_JJ for_IN linkage_NN analysis_NN and_CC therefore_RB require_VB
        construction_NN of_IN accurate_JJ physical_JJ and_CC genetic_JJ maps_NNS ._. Here_RB we_PRP
        employed_VBN BAC_NNP contig_NN and_CC RH_NNP mapping_NN to_TO construct_VB a_DT
        high-resolution_JJ physical_JJ map_NN ,_, which_WDT spans_NNS approximately_RB 7_CD ._. 5_CD
        Mbp_NNP of_IN chromosome_NN 16_CD between_IN markers_NNS D_NNP 16_CD S_NNP 3080_CD and_CC D_NNP 16_CD S_NNP 408_CD ._.
        This_DT map_NN will_MD definitely_RB assist_VB in_IN the_DT refinement_NN of_IN the_DT
        Blau_NNP syndrome_NN locus_JJ as_IN well_RB as_IN other_JJ loci_NN mapping_NN to_TO this_DT
        region_NN ,_, such_JJ as_IN Crohn_NNP 's_POS disease_NN [_NN 5_CD ]_NN ,_, psoriasis_NNS [_NN 8_CD ]_NN and_CC
        possibly_RB ankylosing_VBG spondylitis_NNS [_NN 9_CD 10_CD ]_NN ._.
        We_PRP constructed_VBN a_DT high-resolution_JJ RH_NNP map_NN (_( likelihood_NN
        ratio_NN of_IN greater_JJR than_IN 300_CD :_: 1_CD over_IN the_DT next_JJ likely_JJ order_NN )_)
        with_IN the_DT medium-resolution_JJ G_NNP 3_CD and_CC high-resolution_JJ TNG_NNP
        whole-genome_JJ RH_NNP panels_NNS (_( Figure_NN 1_LS )_) ._. This_DT map_NN allowed_VBD
        ordering_VBG of_IN the_DT polymorphic_JJ markers_NNS and_CC estimation_NN of_IN the_DT
        distances_NNS between_IN them_PRP ._. The_DT marker_NN order_NN provided_VBD the_DT basis_NN
        for_IN construction_NN of_IN the_DT BAC_NNP contig_NN ._. The_DT intermarker_NN
        distances_NNS estimated_VBD from_IN RH_NNP data_NNS were_VBD substantiated_JJ by_IN the_DT
        BAC_NNP contig_NN data_NNS when_WRB the_DT average_JJ length_NN of_IN the_DT BAC_NNP inserts_NNS
        was_VBD used_VBN to_TO estimate_VB intermarker_NN distances_NNS ._. Our_PRP$ BAC_NNP contig_NN
        provides_VBZ more_JJR than_IN 90_CD %_NN coverage_NN of_IN the_DT entire_JJ Blau_NNP
        susceptibility_NN region_NN ._. The_DT STS-based_NNP high-resolution_JJ
        physical_JJ contig_NN consists_VBZ of_IN 124_CD BACs_NNP ,_, and_CC spans_NNS
        approximately_RB 7_CD ._. 5_CD Mb_NNP as_IN estimated_VBN from_IN the_DT number_NN of_IN BACs_NNP
        in_IN the_DT shortest_JJS tiling_VBG path_NN and_CC the_DT average_JJ insert_NN length_NN
        of_IN the_DT BACs_NNP ._. We_PRP have_VBP used_VBN our_PRP$ map_NN to_TO refine_VB the_DT Blau_NNP
        syndrome_NN interval_NN (_( X_NNP ._. Wang_NNP ,_, H_NNP ._. Kuivaniemi_NNP ,_, G_NNP ._. Bonavita_NNP ,_, L_NNP ._.
        Mutkus_NNP ,_, U_NNP ._. Mau_NNP ,_, E_NNP ._. Blau_NNP ,_, N_NNP ._. Inohara_NNP ,_, G_NNP ._. Nunez_NNP ,_, G_NNP ._. Tromp_NNP and_CC
        C_NNP ._. J_NNP ._. Williams_NNP ;_: in_IN press_NN )_) ._.
        Another_DT BAC_NNP contig_NN map_NN of_IN chromosome_NN 16_CD q_NN constructed_VBN by_IN
        two-dimensional_JJ overlapping_VBG oligonucleotide_NN (_( overgo_NN )_)
        hybridization_NN on_IN high-density_JJ BAC_NNP filters_NNS has_VBZ been_VBN
        published_VBN [_NN 23_CD ]_NN ._. This_DT map_NN consists_VBZ of_IN 828_CD overgo_NN markers_NNS
        and_CC 3_CD ,_, 363_CD BACs_NNP providing_VBG >_NN 85_CD %_NN coverage_NN of_IN the_DT long_JJ arm_NN
        of_IN chromosome_NN 16_CD ._. This_DT contig_NN map_NN ,_, however_RB ,_, does_VBZ not_RB cover_VB
        the_DT entire_JJ Blau_NNP syndrome_NN region_NN ;_: it_PRP ends_VBZ at_IN the_DT site_NN of_IN
        marker_NN D_NNP 16_CD S_NNP 2758_CD in_IN our_PRP$ physical_JJ contig_NN (_( see_VB additional_JJ data_NNS
        file_VBP 1_LS )_) ._. The_DT order_NN for_IN most_JJS of_IN the_DT markers_NNS is_VBZ the_DT same_JJ on_IN
        the_DT two_CD independently_RB generated_VBN maps_NNS ._. Nevertheless_RB ,_, there_EX
        are_VBP a_DT few_JJ differences_NNS ._. For_IN example_NN ,_, Han_NNP et_CC al_NN ._. [_NN 23_CD ]_NN
        mapped_VBN the_DT marker_NN D_NNP 16_CD S_NNP 2950_CD in_IN the_DT order_NN of_IN D_NNP 16_CD S_NNP 2623_CD ,_,
        D_NNP 16_CD S_NNP 2950_CD and_CC D_NNP 16_CD S_NNP 744_CD ,_, with_IN the_DT markers_NNS equidistant_NN at_IN
        approximately_RB 130_CD kbp_NN ._. We_PRP found_VBD the_DT order_NN to_TO be_VB D_NNP 16_CD S_NNP 2623_CD ,_,
        D_NNP 16_CD S_NNP 744_CD and_CC D_NNP 16_CD S_NNP 2950_CD with_IN interval_NN of_IN approximately_RB 130_CD kbp_NN
        and_CC 500_CD kbp_NN ,_, respectively_RB ._. Also_RB ,_, the_DT Han_NNP et_CC al_NN ._. [_NN 23_CD ]_NN map_NN
        has_VBZ six_CD regions_NNS in_IN the_DT Blau_NNP susceptibility_NN interval_NN which_WDT
        are_VBP either_CC spanned_VBD with_IN tenuous_JJ support_NN or_CC none_NN at_IN all_DT ._. Two_CD
        are_VBP real_JJ gaps_NNS with_IN no_DT overlapping_VBG clones_NNS and_CC the_DT other_JJ four_CD
        are_VBP spanned_VBD by_IN few_JJ clones_NNS that_WDT have_VBP either_DT unusually_RB long_JJ
        inserts_NNS or_CC are_VBP missing_VBG some_DT of_IN the_DT markers_NNS in_IN the_DT interval_NN ,_,
        or_CC both_DT ._.
        Our_PRP$ contig_NN also_RB contains_VBZ three_CD gaps_NNS that_IN we_PRP were_VBD unable_JJ
        to_TO close_VB by_IN clone_NN walking_NN ._. One_CD of_IN them_PRP corresponds_NNS to_TO one_CD
        of_IN the_DT six_CD gaps_NNS in_IN the_DT Han_NNP et_CC al_NN ._. [_NN 23_CD ]_NN map_NN ._. The_DT other_JJ two_CD
        are_VBP located_VBN in_IN the_DT region_NN between_IN markers_NNS D_NNP 16_CD S_NNP 2758_CD and_CC
        D_NNP 16_CD S_NNP 408_CD ,_, which_WDT is_VBZ not_RB covered_VBN by_IN Han_NNP et_CC al_NN ._. [_NN 23_CD ]_NN ._. The_DT
        common_JJ gap_NN in_IN both_DT physical_JJ contigs_NNS indicates_VBZ either_CC a_DT lack_NN
        of_IN STS_NNP markers_NNS in_IN this_DT region_NN or_CC an_DT under-representation_JJ of_IN
        clones_NNS even_RB though_IN two_CD libraries_NNS were_VBD used_VBN in_IN our_PRP$ study_NN ,_, or_CC
        both_DT ._. We_PRP estimate_VBP from_IN RH_NNP data_NNS that_IN the_DT three_CD gaps_NNS are_VBP only_RB
        425_CD ,_, 530_CD ,_, and_CC 375_CD kbp_NN in_IN size_NN and_CC will_MD not_RB substantially_RB
        affect_VB DNA_NNP linkage_NN analyses_NNS ._. The_DT first_JJ gap_NN (_( see_VB additional_JJ
        data_NNS file_VBP 1_LS )_) ,_, is_VBZ also_RB present_JJ in_IN the_DT FPC_NNP contigs_NNS ,_, between_IN
        ctg_NN 16020_CD and_CC ctg_NN 16021_CD ,_, whereas_IN the_DT other_JJ two_CD have_VBP been_VBN
        filled_VBN in_IN ._.
      
      
        Conclusions_NNP
        We_PRP generated_VBD a_DT high-resolution_JJ physical_JJ map_NN from_IN
        D_NNP 16_CD S_NNP 3080_CD ,_, near_IN D_NNP 16_CD S_NNP 409_CD ,_, and_CC D_NNP 16_CD S_NNP 408_CD (_( 16_CD q_NN 12_CD ._. 1_LS to_TO 16_CD q_NN 13_CD )_)
        because_IN the_DT correct_JJ marker_NN order_NN was_VBD required_VBN for_IN further_JJ
        linkage_NN studies_NNS with_IN Blau_NNP syndrome_NN families_NNS ._. A_DT physical_JJ map_NN
        was_VBD also_RB necessary_JJ to_TO locate_VB ,_, or_CC verify_VB the_DT location_NN of_IN ,_,
        candidate_NN genes_NNS ._. Although_IN there_EX were_VBD substantial_JJ
        discrepancies_NNS as_IN to_TO the_DT location_NN of_IN markers_NNS and_CC genes_NNS at_IN
        the_DT time_NN we_PRP initiated_VBD our_PRP$ mapping_NN project_NN ,_, and_CC even_RB when_WRB
        this_DT physical_JJ map_NN was_VBD assembled_VBN into_IN a_DT final_JJ draft_NN ,_, the_DT
        current_JJ NCBI_NNP map_NN based_VBN on_IN build_VB 29_CD ,_, the_DT FPC_NNP contigs_NNS ,_, and_CC
        the_DT map_NN produced_VBN here_RB ,_, agree_VBP remarkably_RB well_RB ._. The_DT
        convergence_NN of_IN three_CD independently_RB constructed_VBN maps_NNS based_VBN
        on_IN different_JJ approaches_NNS ,_, suggests_VBZ that_IN the_DT current_JJ maps_NNS are_VBP
        reliable_JJ ,_, will_MD perhaps_RB undergo_VB minor_JJ changes_NNS ,_, and_CC will_MD be_VB
        useful_JJ for_IN mapping_NN of_IN disease_NN loci_NN to_TO the_DT interval_NN ._.
      
      
        Materials_NNS and_CC Methods_NNP
        
          PCR_NNP of_IN STS_NNP markers_NNS
          Primer_NNP pairs_NNS for_IN most_JJS of_IN the_DT STS_NNP markers_NNS were_VBD
          purchased_VBN from_IN Research_NNP Genetics_NNP ,_, and_CC some_DT primers_NNS were_VBD
          synthesized_JJ by_IN Integrated_NNP DNA_NNP Technologies_NNPS ,_, Inc_NNP ._. All_DT test_NN
          PCRs_NNP were_VBD carried_VBN out_IN using_VBG 30_CD ng_NN of_IN template_NN DNA_NNP with_IN
          1_CD ._. 5_CD μl_NN GeneAmp_NNP 10_CD ×_NN PCR_NNP buffer_NN II_NNP (_( Roche_NNP Molecular_NNP
          Systems_NNPS ,_, Inc_NNP ._. )_) ,_, either_CC 1_CD ._. 5_CD mM_NN or_CC 3_CD ._. 0_CD mM_NN Mg_NNP 2_CD +_NN ,_, 200_CD μM_NN
          dNTPs_NNS ,_, 0_CD ._. 2_CD μM_NN each_DT forward_RB and_CC reverse_VB primer_NN ,_, and_CC 0_CD ._. 375_CD
          units_NNS of_IN AmpliTaq_NNP Gold_NNP Polymerase_NNP (_( Roche_NNP Molecular_NNP
          Systems_NNPS ,_, Inc_NNP ._. )_) in_IN a_DT 15_CD μl_NN final_JJ volume_NN ._. PCRs_NNP were_VBD
          performed_VBN in_IN a_DT model_NN 9600_CD Thermocycler_NNP (_( Perkin-_NNP Elmer_NNP
          Cetus_NNP )_) using_VBG the_DT following_NN cycling_NN protocol_NN :_: initial_JJ
          denaturation_NN at_IN 94_CD °_NN C_NNP for_IN 10_CD min_NN ;_: 94_CD ._. 5_LS °_NN C_NNP for_IN 1_CD min_NN ,_,
          55_CD -_: 60_CD °_NN C_NNP for_IN 1_CD min_NN ,_, 72_CD °_NN C_NNP for_IN 40_CD s_VBZ for_IN 35_CD cycles_NNS ;_: followed_VBN
          by_IN a_DT final_JJ extension_NN at_IN 72_CD °_NN C_NNP for_IN 3_CD min_NN ._. PCR_NNP products_NNS were_VBD
          analyzed_VBN on_IN 2_CD %_NN agarose_NN gels_NNS ._.
          Genotyping_NNP with_IN polymorphic_JJ di-_NN ,_, tri-_NN ,_, or_CC
          tetranucleotide-repeat_JJ markers_NNS was_VBD performed_VBN by_IN PCR_NNP
          according_VBG to_TO the_DT conditions_NNS used_VBN in_IN the_DT test_NN PCRs_NNP above_IN
          except_IN that_DT one_CD of_IN the_DT primers_NNS was_VBD 32_CD P-_NNP labeled_VBD with_IN T_NN 4_CD
          polynucleotide_NN kinase_NN ._. Products_NNPS were_VBD separated_JJ on_IN 7_CD %_NN
          denaturing_VBG polyacrylamide_NN gels_NNS with_IN or_CC without_IN 50_CD %_NN
          formamide_NN (_( Sequagel-_NNP 6_CD or_CC Accugel_NNP 19_CD :_: 1_CD ;_: National_NNP
          Diagnostics_NNPS )_) ._.
        
        
          Construction_NNP of_IN a_DT RH_NNP map_NN
          The_DT Whitehead_NNP Institute_NNP GeneBridge_NNP 4_CD ,_, and_CC Stanford_NNP G_NNP 3_CD
          and_CC TNG_NNP whole_JJ genome_NN RH_NNP panels_NNS (_( Research_NNP Genetics_NNP )_) were_VBD
          used_VBN to_TO construct_VB a_DT RH_NNP map_NN ._. Before_IN typing_VBG the_DT hybrid_JJ
          panels_NNS ,_, the_DT PCR_NNP conditions_NNS for_IN STS_NNP markers_NNS were_VBD
          determined_VBN using_VBG hamster_NN and_CC human_JJ genomic_JJ DNA_NNP as_IN control_NN
          templates_NNS ._. PCR_NNP products_NNS were_VBD separated_JJ on_IN agarose_NN gels_NNS ._.
          PCRs_NNP with_IN a_DT band_NN of_IN appropriate_JJ size_NN were_VBD considered_VBN
          positive_JJ and_CC scored_VBD as_IN 1_CD ,_, negative_JJ PCRs_NNP as_IN 0_CD and_CC
          ambiguous_JJ PCRs_NNP with_IN bands_NNS of_IN unexpected_JJ size_NN as_IN 2_CD ._. The_DT
          GeneBridge_NNP 4_CD RH_NNP map_NN was_VBD constructed_VBN using_VBG a_DT publicly_RB
          available_JJ server_NN at_IN the_DT Whitehead_NNP Institute_NNP at_IN the_DT
          Massachusetts_NNP Institute_NNP of_IN Technology_NNP ._. The_DT G_NNP 3_CD and_CC TNG_NNP
          maps_NNS were_VBD generated_VBN using_VBG the_DT RHMAP_NNP 3_CD ._. 0_CD program_NN package_NN [_NN
          14_CD ]_NN ._. The_DT RH_NNP 2_CD PT_NNP program_NN was_VBD used_VBN initially_RB to_TO determine_VB
          two-point_JJ lod_NN scores_NNS and_CC all_PDT the_DT markers_NNS were_VBD divided_VBN
          into_IN different_JJ linkage_NN groups_NNS ._. Markers_NNP in_IN different_JJ
          linkage_NN groups_NNS were_VBD used_VBN to_TO carry_VB out_IN maximum_NN likelihood_NN
          calculations_NNS to_TO estimate_VB breakage_NN probabilities_NNS and_CC
          distances_NNS between_IN markers_NNS using_VBG another_DT program_NN RHMAXLIK_NNP ._.
          We_PRP established_VBD a_DT G_NNP 3_CD framework_NN map_NN of_IN a_DT subset_NN of_IN
          approximately_RB evenly_RB spaced_JJ markers_NNS ._. Additional_JJ markers_NNS
          were_VBD mapped_VBN in_IN overlapping_VBG sets_NNS with_IN G_NNP 3_CD panel_NN data_NNS until_IN
          the_DT likelihood_NN ratio_NN dropped_VBD below_IN threshold_NN ._. Clusters_NNP of_IN
          closely_RB spaced_JJ markers_NNS around_IN framework_NN markers_NNS were_VBD then_RB
          mapped_VBN using_VBG the_DT TNG_NNP data_NN and_CC RHMAXLIK_NNP ._. Map_NNP orders_NNS were_VBD
          verified_VBN by_IN performing_VBG independent_JJ estimations_NNS of_IN
          likelihood_NN but_CC including_VBG markers_NNS from_IN adjacent_JJ
          clusters_NNS ._.
        
        
          Screening_NNP of_IN BAC_NNP libraries_NNS
          A_DT BAC_NNP library_NN ,_, CITB_NNP ,_, which_WDT was_VBD generated_VBN at_IN the_DT
          California_NNP Institute_NNP of_IN Technology_NNP in_IN the_DT form_NN of_IN DNA_NNP
          pools_NNS arranged_VBD in_IN microtiter_NN plates_NNS ,_, was_VBD purchased_VBN
          (_( Research_NNP Genetics_NNP )_) ._. This_DT library_NN offers_VBZ approximately_RB
          six-fold_RB coverage_NN of_IN the_DT whole_JJ genome_NN with_IN an_DT average_JJ
          insert_NN size_NN of_IN 130_CD kbp_NN ._. The_DT library_NN is_VBZ comprised_VBN of_IN
          147_CD ,_, 456_CD distinct_JJ recombinants_NNS ._. For_IN rapid_JJ screening_NN ,_, DNAs_NNP
          from_IN the_DT clones_NNS had_VBD been_VBN pooled_VBN into_IN 48_CD superpools_NNS ,_, each_DT
          representing_VBG eight_CD 384_CD -_: well_RB plates_NNS that_WDT were_VBD pooled_VBN into_IN
          eight_CD plate_NN pools_NNS ,_, 16_CD row_NN pools_NNS ,_, and_CC 24_CD column_NN pools_NNS ._.
          PCR-based_NNP screening_NN consisted_VBD of_IN identifying_VBG positive_JJ
          superpools_NNS followed_VBN by_IN screening_VBG of_IN the_DT appropriate_JJ
          plate_NN ,_, row_NN and_CC column_NN pools_NNS ._. Typically_RB ,_, the_DT
          three-dimensional_JJ screening_NN identified_VBD one_CD or_CC more_RBR unique_JJ
          BAC_NNP clones_NNS from_IN the_DT 3_CD ,_, 072_CD BAC_NNP clones_NNS in_IN a_DT superpool_NN ._.
          Occasionally_RB ,_, multiple_JJ positives_NNS in_IN a_DT single_JJ plate_NN
          (_( plate_NN ,_, row_NN ,_, column_NN )_) resulted_VBD in_IN non-unique_JJ positives_NNS
          (_( these_DT also_RB generated_VBN false-positives_JJ )_) ._. PCRs_NNP were_VBD
          performed_VBN as_IN described_VBN above_IN except_IN that_DT 1_CD μl_NN of_IN pooled_VBN
          BAC_NNP library_NN DNA_NNP was_VBD used_VBN as_IN template_NN and_CC the_DT annealing_VBG
          temperature_NN for_IN most_JJS markers_NNS was_VBD raised_VBN to_TO 60_CD °_NN C_NNP to_TO
          achieve_VB greater_JJR specificity_NN ._.
          High-density_NNP filters_NNS of_IN the_DT Roswell_NNP Park_NNP Cancer_NNP
          Institute_NNP human_JJ RPCI-_NNP 11_CD BAC_NNP clones_NNS were_VBD purchased_VBN from_IN
          BACPAC_NNP Resource_NNP Center_NNP at_IN the_DT Children_NNP 's_POS Hospital_NNP Oakland_NNP
          Research_NNP Institute_NNP in_IN Oakland_NNP ,_, CA_NNP ._. Segments_NNP 1_CD and_CC 2_CD of_IN
          RPCI-_NNP 11_CD ,_, with_IN a_DT total_NN of_IN 218_CD ,_, 995_CD colonies_NNS corresponding_JJ
          to_TO approximately_RB twelve-fold_JJ genomic_JJ coverage_NN ,_, were_VBD used_VBN ._.
          The_DT filters_NNS were_VBD screened_VBD iteratively_RB by_IN hybridization_NN
          with_IN pools_NNS of_IN RNA_NNP probes_NNS prepared_VBN from_IN the_DT ends_NNS of_IN BAC_NNP
          clones_NNS identified_VBN either_CC by_IN PCR-screening_NNP or_CC prior_RB rounds_NNS
          of_IN hybridization_NN ._. Hybridizations_NNP were_VBD performed_VBN using_VBG
          ULTRAhyb_NNP buffer_NN (_( Ambion_NNP )_) and_CC components_NNS of_IN the_DT Strip-_NNP EZ_NNP
          RNA_NNP kit_NN (_( Ambion_NNP )_) ._.
          Prior_RB to_TO pooling_VBG ,_, the_DT probes_NNS were_VBD tested_VBN individually_RB
          for_IN the_DT presence_NN of_IN repetitive_JJ elements_NNS by_IN Southern_NNP
          hybridization_NN to_TO the_DT parent_JJ BAC_NNP DNA_NNP and_CC complete_JJ 
          Hin_NNP d_SYM III_NNP digests_NNS of_IN human_JJ DNA_NNP ._.
          Probes_NNP that_WDT demonstrated_VBD a_DT pattern_NN consistent_JJ with_IN the_DT
          presence_NN of_IN repetitive_JJ elements_NNS were_VBD excluded_VBN ._.
        
        
          Field-inversion_NNP gel_NN electrophoresis_NNS (_( FIGE_NNP )_)
          To_TO determine_VB the_DT size_NN of_IN important_JJ BAC_NNP inserts_NNS ,_, 2_CD μg_NN
          of_IN BAC_NNP DNA_NNP was_VBD first_RB digested_VBN with_IN 10_CD units_NNS of_IN 
          Not_RB I_PRP (_( New_NNP England_NNP Biolabs_NNP )_) ._. DNA_NN
          fragments_NNS were_VBD then_RB separated_JJ on_IN 1_CD %_NN pulsed_JJ field_NN
          certified_VBN agarose_NN gel_NN (_( Bio-_NNP Rad_NNP )_) in_IN 0_CD ._. 5_CD ×_NN GTBE_NNP buffer_NN (_( 0_CD ._. 5_LS
          ×_NN TBE_NNP ,_, 0_CD ._. 1_CD M_NNP glycine_NN )_) by_IN FIGE_NNP with_IN a_DT PC_NN 750_CD Pulse_NNP
          Controller_NNP (_( Hoefer_NNP Scientific_NNP Instruments_NNP )_) ._. The_DT samples_NNS
          were_VBD prerun_NN at_IN 12_CD °_NN C_NNP and_CC 8_CD V_NNP /_NN cm_NN for_IN 1_CD h_NN ,_, and_CC then_RB run_VB
          continuously_RB for_IN 17_CD h_NN with_IN forward_RB pulse_NN 1_CD ._. 2_CD s_VBZ ,_, reverse_VB
          pulse_NN 0_CD ._. 4_CD s_VBZ and_CC timing_NN ramp_NN 0_CD ._. 8_CD /_NN h_NN ._. A_DT Low-_NNP Range_NNP PFG_NNP Marker_NNP
          (_( 0_CD ._. 13_CD -_: 194_CD kbp_NN )_) (_( New_NNP England_NNP Biolabs_NNP )_) was_VBD used_VBN for_IN
          estimation_NN of_IN BAC_NNP insert_VB sizes_NNS ._. After_IN electrophoresis_NNS ,_,
          the_DT gel_NN was_VBD stained_JJ with_IN ethidium_NN bromide_NN ,_, visualized_JJ ,_,
          and_CC photographed_VBN with_IN a_DT GelPrint_NNP 2000_CD i_NNP system_NN
          (_( BioPhotonics_NNP )_) ._.
        
        
          Verification_NNP of_IN positive_JJ BAC_NNP clones_NNS
          Screening_NNP for_IN BAC_NNP clones_NNS ,_, either_CC by_IN PCR_NNP of_IN pooled_VBN DNA_NNP ,_,
          or_CC by_IN hybridisation_NN ,_, produced_VBD a_DT wide_JJ range_NN of_IN signal_NN
          intensities_NNS ._. Although_IN differences_NNS in_IN signal_NN intensity_NN may_MD
          be_VB considered_VBN as_IN a_DT measure_NN of_IN the_DT evidence_NN for_IN the_DT
          clones_NNS '_POS positions_NNS in_IN the_DT contig_NN ,_, the_DT variability_NN of_IN input_NN
          target_NN DNA_NNP made_VBD the_DT conclusions_NNS unreliable_JJ ._. Positive_JJ
          clones_NNS were_VBD therefore_RB rescreened_JJ by_IN PCR_NNP with_IN STS_NNP markers_NNS
          in_IN the_DT vicinity_NN to_TO eliminate_VB false_JJ positive_NN ._.
          Positive_JJ clones_NNS were_VBD purchased_VBN from_IN Research_NNP Genetics_NNP
          and_CC colony-blot_JJ filters_NNS were_VBD prepared_VBN using_VBG a_DT Biomek_NNP 1000_CD
          Automated_NNP Laboratory_NNP Workstation_NNP with_IN a_DT 96_CD -_: pin_VB replicator_NN
          (_( Beckman_NNP Coulter_NNP )_) ._. The_DT gridded_JJ colony-blots_JJ were_VBD screened_VBD
          with_IN individual_JJ RNA_NNP probes_NNS from_IN the_DT pools_NNS above_IN ._. All_DT
          positive_JJ clones_NNS were_VBD confirmed_VBN by_IN PCR_NNP with_IN appropriate_JJ
          primer_NN pairs_NNS ._.
        
        
          Preparation_NNP of_IN RNA_NNP probes_NNS from_IN the_DT ends_NNS of_IN BAC_NNP
          clones_NNS
          BAC_NNP DNAs_NNP from_IN standard_JJ alkaline_NN lysis_NNS preparations_NNS [_NN
          24_CD ]_NN were_VBD completely_RB digested_VBN with_IN 
          Hin_NNP d_SYM III_NNP ._. RNA_NNP probes_NNS were_VBD
          synthesized_JJ from_IN the_DT ends_NNS of_IN clones_NNS by_IN run-off_JJ
          transcription_NN using_VBG the_DT Strip-_NNP EZ_NNP RNA_NNP kit_NN (_( Ambion_NNP )_) and_CC
          32_CD P-UTP_NNP (_( ICN_NNP Radiochemicals_NNP )_) ._. Unincorporated_NNP nucleotides_NNS
          were_VBD removed_VBN by_IN size-exclusion_JJ chromatography_NN on_IN
          RNase-free_NNP Sephadex_NNP G-_NNP 50_CD (_( Sigma_NNP )_) spin_VB columns_NNS ._.
        
        
          Candidate_NNP genes_NNS
          Four_CD genes_NNS ,_, namely_RB ,_, CES_NNP 1_CD ,_, MMP_NNP 2_CD ,_, MMP_NNP 15_CD ,_, and_CC SCYA_NNP 17_CD ,_,
          were_VBD selected_VBN based_VBN on_IN their_PRP$ biochemical_JJ function_NN and_CC
          physical_JJ map_NN locations_NNS prior_RB to_TO completion_NN of_IN our_PRP$
          high-resolution_JJ map_NN ._. DNA_NN sequences_NNS for_IN the_DT four_CD genes_NNS
          were_VBD obtained_VBN from_IN GenBank_NNP (_( accession_NN numbers_NNS for_IN CES_NNP 1_CD :_:
          D_NNP 21077_CD ;_: MMP_NNP 2_CD :_: U_NNP 96098_CD ;_: MMP_NNP 15_CD :_: Z_NNP 48482_CD ;_: SCYA_NNP 17_CD :_: AC_NNP 004382_CD )_) ._.
          Primers_NNP to_TO be_VB used_VBN in_IN PCR_NNP for_IN each_DT gene_NN were_VBD designed_VBN
          using_VBG the_DT Wisconsin_NNP Package_NNP Version_NNP 10_CD ._. 0_CD (_( Genetics_NNP
          Computer_NNP Group_NNP )_) and_CC synthesized_JJ by_IN Operon_NNP Technologies_NNPS ,_,
          Inc_NNP ._. PCR_NNP conditions_NNS other_JJ than_IN annealing_VBG temperature_NN used_VBN
          were_VBD the_DT same_JJ as_IN described_VBN above_IN ._.
          The_DT physical_JJ locations_NNS of_IN the_DT four_CD genes_NNS studied_VBN were_VBD
          verified_VBN by_IN using_VBG RH_NNP panels_NNS as_IN described_VBN below_IN ._. Their_PRP$
          locations_NNS were_VBD further_RBR refined_VBN by_IN screening_VBG a_DT BAC_NNP
          library_NN ,_, as_IN discussed_VBN below_IN ,_, using_VBG gene-specific_JJ PCR_NNP
          primers_NNS ._. MMP_NNP 15_CD and_CC SCYA_NNP 17_CD were_VBD located_VBN telomeric_JJ to_TO
          D_NNP 16_CD S_NNP 408_CD and_CC thus_RB outside_IN the_DT Blau_NNP syndrome_NN interval_NN and_CC
          were_VBD excluded_VBN from_IN further_JJ studies_NNS ._. MMP_NNP 2_CD was_VBD placed_VBN
          outside_IN of_IN a_DT refined_VBN Blau_NNP syndrome_NN interval_NN that_WDT excluded_VBD
          several_JJ cM_NN centromeric_JJ from_IN D_NNP 16_CD S_NNP 408_CD ._.
          A_DT 755_CD bp_NN region_NN ,_, nucleotide_NN position_NN -_: 660_CD to_TO +_NN 95_CD ,_, of_IN
          the_DT CES_NNP 1_CD gene_NN was_VBD amplified_VBN by_IN PCR_NNP from_IN 33_CD members_NNS from_IN
          five_CD families_NNS with_IN the_DT Blau_NNP syndrome_NN ._. PCR_NNP products_NNS were_VBD
          purified_JJ (_( GENECLEAN_NNP III_NNP ,_, BIO_NNP 101_CD Inc_NNP ._. )_) to_TO remove_VB primers_NNS
          and_CC other_JJ reagents_NNS ,_, and_CC sequenced_JJ (_( Thermo_NNP Sequenase_NNP ®_NN ,_,
          Amersham_NNP Life_NNP Science_NNP ,_, Inc_NNP ._. )_) ._. Haplotypes_NNP were_VBD derived_VBN
          from_IN the_DT inheritance_NN of_IN the_DT variants_NNS in_IN the_DT families_NNS
          (_( families_NNS not_RB shown_VBN )_) ._. Sequencing_NNP products_NNS were_VBD separated_JJ
          on_IN 7_CD %_NN glycerol-tolerant_JJ polyacrylamide_NN sequencing_VBG gels_NNS
          (_( National_NNP Diagnostics_NNPS )_) ._.
          To_TO verify_VB that_IN the_DT gene_NN for_IN CARD_NNP 15_CD is_VBZ located_VBN in_IN the_DT
          contig_NN ,_, a_DT 444_CD bp_NN genomic_JJ region_NN ,_, corresponding_JJ to_TO
          nucleotide_NN position_NN 976_CD to_TO 1227_CD of_IN the_DT CARD_NNP 15_CD transcript_NN
          (_( NM_NNP __NN 022162_CD ._. 1_LS )_) was_VBD amplified_VBN from_IN BAC_NNP clones_NNS ._. Clone_NNP 327_CD F_NN 22_CD
          yielded_VBD a_DT band_NN of_IN appropriate_JJ size_NN ._.
        
      
      
        List_NN of_IN Abbreviations_NNP
        BAC_NNP Bacterial_NNP artificial_JJ chromosome_NN
        BES_NNP BAC_NNP end_NN sequence_NN
        CC_NNP group_NN Group_NNP of_IN chemokines_NNS with_IN Cys-_NNP X-C_NNP ys_NNS motif_NN
        CES_NNP 1_CD Carboxylesterase_NNP 1_CD
        CITB_NNP California_NNP Institute_NNP of_IN Technology_NNP BAC_NNP
        EST_NNP Expressed_NNP sequence_NN tag_NN
        FIGE_NNP Field_NNP inversion_NN gel_NN electrophoresis_NNS
        G_NNP 3_CD Stanford_NNP G_NNP 3_CD radiation_NN hybrid_JJ panel_NN
        GTBE_NNP Glucose_NNP TBE_NNP
        HTGS_NNP High-throughput_NNP genomic_JJ sequences_NNS
        MMP_NNP Matrix_NNP metalloproteinase_NN
        MMP_NNP 15_CD Matrix_NNP metalloproteinase_NN 15_CD
        MMP_NNP 2_CD Matrix_NNP metalloproteinase_NN 2_CD
        NCBI_NNP National_NNP Center_NNP for_IN Biotechnology_NNP Information_NNP
        PEP_NNP Primer-extension_NNP preamplification_NN
        RH_NNP Radiation_NNP hybrid_JJ
        RPCI_NNP Roswell_NNP Park_NNP Cancer_NNP Institute_NNP
        SCYA_NNP 17_CD Small_JJ inducible_JJ cytokine_NN subfamily_RB A_DT (_( Cys-_NNP Cys_NNP )_) ,_,
        member_NN 17_CD
        STS_NNP Sequence_NNP tagged_VBN site_NN
        TBE_NNP Tris_NNP Borate_NNP EDTA_NNP buffer_NN
        TNG_NNP Stanford_NNP TNG_NNP radiation_NN hybrid_JJ panel_NN
      
      
        Authors_NNP '_'' contributions_NNS
        Author_NN 1_CD (_( XW_NNP )_) performed_VBN typing_VBG and_CC hybridisation_NN
        experiments_NNS necessary_JJ to_TO construct_VB the_DT RH_NNP map_NN and_CC BAC_NNP
        contig_NN ,_, participated_VBD in_IN the_DT writing_VBG and_CC editing_NN the_DT
        manuscript_NN ;_: the_DT work_NN described_VBD here_RB constituted_VBD a_DT portion_NN
        of_IN his_PRP$ Ph_NNP ._. D_NNP ._. dissertation_NN ._. Author_NN 2_CD (_( HK_NNP )_) participated_VBD in_IN
        the_DT design_NN and_CC implementation_NN of_IN the_DT study_NN ,_, contributed_VBD to_TO
        writing_VBG and_CC revising_VBG the_DT manuscript_NN ._. Author_NN 3_CD (_( GB_NNP )_)
        performed_VBD some_DT of_IN the_DT BAC_NNP DNA_NNP isolation_NN and_CC genotyping_VBG ._.
        Author_NN 4_CD (_( CJW_NNP )_) participated_VBD in_IN the_DT design_NN and_CC
        implementation_NN of_IN the_DT study_NN ,_, provided_VBN supervision_NN of_IN GB_NNP ,_,
        and_CC obtained_VBD funding_NN for_IN the_DT study_NN ._. Author_NN 5_CD (_( GT_NNP )_) provided_VBN
        guidance_NN to_TO XW_NNP ,_, participated_VBD in_IN the_DT design_NN and_CC
        implementation_NN of_IN the_DT study_NN ,_, writing_VBG and_CC editing_NN the_DT
        manuscript_NN and_CC obtained_VBN funding_NN for_IN the_DT study_NN ._.
      
    
  
